source
- Setbacks for Novartis; Anthropic looks for a dealmaker; and moreWelcome back to another edition of Endpoints Weekly! While it is still technically summer, the season is starting to turn now that we’re past Labor Day. It will be a sprint to Thanksgiving, and we’…Endpoints · 35m ago↗ source
- Disc sets up polycythemia vera challenge but Silence maintains leadThe polycythemia vera field is heating up, with Disc Medicine and Silence Therapeutics each advancing next-generation therapies, playing catch-up to Takeda and Protagonist Therapeutics, who won the…